NOVEL HMGB1-INHIBITING THERAPEUTIC AGENTS FOR EXPERIMENTAL SEPSIS

被引:124
作者
Wang, Haichao [1 ,2 ]
Ward, Mary F. [2 ]
Sama, Andrew E. [2 ]
机构
[1] N Shore LIJ Hlth Syst, Feinstein Inst Med Res, Manhasset, NY 11030 USA
[2] NYU, Sch Med, N Shore Univ Hosp, Dept Emergency Med, Manhasset, NY USA
来源
SHOCK | 2009年 / 32卷 / 04期
基金
美国国家卫生研究院;
关键词
Innate immune cells; phagocytes; inflammation; cytokines; sepsis; antibodies; HMGB1; tanshinones; MOBILITY GROUP BOX-1; NECROSIS-FACTOR-ALPHA; GRAM-NEGATIVE BACTEREMIA; CHROMATIN PROTEIN HMGB1; GLYCATION END-PRODUCTS; ACUTE LUNG INJURY; HIGH-MOBILITY-GROUP-BOX-1; PROTEIN; LETHAL SEPSIS; SEPTIC SHOCK; MONOCLONAL-ANTIBODY;
D O I
10.1097/SHK.0b013e3181a551bd
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Sepsis refers to a systemic inflammatory response syndrome resulting from a microbial infection. The inflammatory response is partly mediated by innate immune cells (such as macrophages, monocytes, and neutrophils), which not only ingest and eliminate invading pathogens but also initiate an inflammatory response by producing early (e.g., TNF and IFN-gamma and late (e.g., high-mobility group box [HMGB1]) proinflammatory cytokines. Here, we briefly review emerging evidence that support extracellular HMGB1 as a late mediator of experimental sepsis and discuss therapeutic potential of several HMGB1-inhibiting agents (including neutralizing antibodies and steroid-like tanshinones) in experimental sepsis.
引用
收藏
页码:348 / 357
页数:10
相关论文
共 143 条
[11]   CYTOKINES - SOLUBLE FACTORS IN IMMUNE-RESPONSES [J].
BALKWILL, F .
CURRENT OPINION IN IMMUNOLOGY, 1988, 1 (02) :241-249
[12]   The extracellular release of HMGB1 during apoptotic cell death [J].
Bell, Charles W. ;
Jiang, Weiwen ;
Reich, Charles F., III ;
Pisetsky, David S. .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2006, 291 (06) :C1318-C1325
[13]   PASSIVE-IMMUNIZATION AGAINST CACHECTIN TUMOR NECROSIS FACTOR PROTECTS MICE FROM LETHAL EFFECT OF ENDOTOXIN [J].
BEUTLER, B ;
MILSARK, IW ;
CERAMI, AC .
SCIENCE, 1985, 229 (4716) :869-871
[14]   Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion [J].
Bonaldi, T ;
Talamo, F ;
Scaffidi, P ;
Ferrera, D ;
Porto, A ;
Bachi, A ;
Rubartelli, A ;
Agresti, A ;
Bianchi, ME .
EMBO JOURNAL, 2003, 22 (20) :5551-5560
[15]   Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin [J].
Borovikova, LV ;
Ivanova, S ;
Zhang, MH ;
Yang, H ;
Botchkina, GI ;
Watkins, LR ;
Wang, HC ;
Abumrad, N ;
Eaton, JW ;
Tracey, KJ .
NATURE, 2000, 405 (6785) :458-462
[16]   Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis [J].
Bozza, M ;
Satoskar, AR ;
Lin, GS ;
Lu, B ;
Humbles, AA ;
Gerard, C ;
David, JR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (02) :341-346
[17]   Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors [J].
Brightbill, HD ;
Libraty, DH ;
Krutzik, SR ;
Yang, RB ;
Belisle, JT ;
Bleharski, JR ;
Maitland, M ;
Norgard, MV ;
Plevy, SE ;
Smale, ST ;
Brennan, PJ ;
Bloom, BR ;
Godowski, PJ ;
Modlin, RL .
SCIENCE, 1999, 285 (5428) :732-736
[18]   Revised nomenclature for high mobility group (HMG) chromosomal proteins [J].
Bustin, M .
TRENDS IN BIOCHEMICAL SCIENCES, 2001, 26 (03) :152-153
[19]  
BUSTIN M, 2002, SCI STKE, pPE39
[20]   Protection from septic shock by neutralization of macrophage migration inhibitory factor [J].
Calandra, T ;
Echtenacher, B ;
Le Roy, D ;
Pugin, J ;
Metz, CN ;
Hültner, L ;
Heumann, D ;
Männel, D ;
Bucala, R ;
Glauser, MP .
NATURE MEDICINE, 2000, 6 (02) :164-170